Literature DB >> 32680837

Experience of a novel community testing programme for COVID-19 in London: Lessons learnt.

Gabriel Wallis1, Francesca Siracusa2, Michael Blank1, Helena Painter1, Javier Sanchez1, Kelcy Salinas1, Cherifer Mamuyac1, Cindy Marudamuthu1, Fenella Wrigley3, Tumena Corrah1, Tommy Rampling4, Sarah Logan4, Anna Goodman5, Deborah Miller5, Bhanu Williams1, Alastair McGregor1, Victoria Parris1, Gurjinder Sandhu1, Laurence John1, Padmasayee Papineni1, Ashley Whittington6.   

Abstract

We describe the London community testing programme developed for COVID-19, audit its effectiveness and report patient acceptability and patient adherence to isolation guidance, based upon a survey conducted with participants.Any patients meeting the Public Health England (PHE) case definition for COVID-19 who did not require hospital admission were eligible for community testing. 2,053 patients with suspected COVID-19 were tested in the community between January and March 2020. Of those tested, 75 (3.6%) were positive. 88% of patients that completed a patient survey felt safe and 82% agreed that community testing was preferable to hospital admission. 97% were able to remain within their own home during the isolation period but just 41% were able to reliably isolate from other members of their household.The London community testing programme allowed widespread testing for COVID-19 while minimising patient transport, hospital admissions and staff exposures. Community testing was acceptable to patients and preferable to admission to hospital. Patients were able to reliably isolate in their home but not from household contacts. The authors believe in the importance, feasibility and acceptability of community testing for COVID-19 as a part of a package of interventions to mitigate a second wave of infection. © Royal College of Physicians 2020. All rights reserved.

Entities:  

Keywords:  COVID-19; HCID; community screening; self-isolation; survey

Mesh:

Year:  2020        PMID: 32680837      PMCID: PMC7539734          DOI: 10.7861/clinmed.2020-0436

Source DB:  PubMed          Journal:  Clin Med (Lond)        ISSN: 1470-2118            Impact factor:   2.659


  5 in total

1.  Clinical characteristics of 140 patients infected with SARS-CoV-2 in Wuhan, China.

Authors:  Jin-Jin Zhang; Xiang Dong; Yi-Yuan Cao; Ya-Dong Yuan; Yi-Bin Yang; You-Qin Yan; Cezmi A Akdis; Ya-Dong Gao
Journal:  Allergy       Date:  2020-02-27       Impact factor: 13.146

2.  Drive-through testing in COVID-19: experience from NHS Lothian.

Authors:  Katherine Hill; Robyn Campbell; Callum Mutch; Oliver Koch; Claire Mackintosh
Journal:  Clin Med (Lond)       Date:  2020-05-01       Impact factor: 2.659

3.  Early administration of oral oseltamivir increases the benefits of influenza treatment.

Authors:  F Y Aoki; M D Macleod; P Paggiaro; O Carewicz; A El Sawy; C Wat; M Griffiths; E Waalberg; P Ward
Journal:  J Antimicrob Chemother       Date:  2003-01       Impact factor: 5.790

4.  Coronavirus disease (COVID-19) Community Testing Team in Scotland: A 14-day review, 6 to 20 February 2020.

Authors:  Kate Mark; Katie Steel; Janet Stevenson; Christine Evans; Duncan McCormick; Lorna Willocks; Alison McCallum; Laura Jones; Ingolfur Johannessen; Kate Templeton; Oliver Koch; Claire Mackintosh
Journal:  Euro Surveill       Date:  2020-03

5.  Drive-Through Screening Center for COVID-19: a Safe and Efficient Screening System against Massive Community Outbreak.

Authors:  Ki Tae Kwon; Jae Hoon Ko; Heejun Shin; Minki Sung; Jin Yong Kim
Journal:  J Korean Med Sci       Date:  2020-03-23       Impact factor: 2.153

  5 in total
  4 in total

1.  Cross-sectional observational study of epidemiology of COVID-19 and clinical outcomes of hospitalised patients in North West London during March and April 2020.

Authors:  Guduru Gopal Rao; Alexander Allen; Padmasayee Papineni; Liyang Wang; Charlotte Anderson; Alastair McGregor; Ashley Whittington; Laurence John; Miriam Harris; Stephen Hiles; Thomas Nicholas; Katherine Adams; Ayesha Akbar; Paula Blomquist; Valerie Decraene; Bharat Patel; Rohini Manuel; Yimmy Chow; Martin Kuper
Journal:  BMJ Open       Date:  2021-02-18       Impact factor: 2.692

2.  Cardiovascular outcomes in patients with chronic kidney disease and COVID-19: a multi-regional data-linkage study.

Authors:  Emilie J Lambourg; Peter J Gallacher; Robert W Hunter; Moneeza Siddiqui; Eve Miller-Hodges; James Chalmers; Dan Pugh; Neeraj Dhaun; Samira Bell
Journal:  Eur Respir J       Date:  2022-05-12       Impact factor: 33.795

3.  Global Experiences of Community Responses to COVID-19: A Systematic Literature Review.

Authors:  Yijin Wu; Quan Zhang; Meiyu Li; Qingduo Mao; Linzi Li
Journal:  Front Public Health       Date:  2022-07-19

Review 4.  Knowledge, Attitudes, and Behavior Related to COVID-19 Testing: A Rapid Scoping Review.

Authors:  Imogen Bevan; Mats Stage Baxter; Helen R Stagg; Alice Street
Journal:  Diagnostics (Basel)       Date:  2021-09-15
  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.